Technological Breakthroughs in Domestic Fluorosilicone Oil: Precision Control of Fluorine Content and High-End Mass Production Achieved


      In early 2026, the domestic fluorosilicone oil sector witnessed multiple key technological breakthroughs. A patented technology enabling continuous adjustment of fluorine content between 5% and 70% has drawn industry-wide attention, while multiple producers have successively achieved mass production of high-end medical-grade and aerospace-grade fluorosilicone oil, accelerating import substitution and reshaping the high-end market long dominated by overseas giants.
      The fluorosilicone oil industry welcomed a “new year‘s gift” of technological innovation in early 2026. According to information from the National Intellectual Property Administration, a patent titled “A Method for Preparing Fluorine-Content-Controllable Fluorosilicone Oil” (Publication No. CN121319371A) was jointly applied for by a Hubei-based silicon material company and a chemical enterprise, marking a significant breakthrough in precise molecular structure design of fluorosilicone oil in China.

Core Technological Breakthrough: Continuous Adjustment of Fluorine Content
       According to the patent abstract, the technology achieves continuous adjustment of fluorine content in the range of 5-70 wt% by precisely controlling the feed ratio of fluorinated silane monomers to non-fluorinated silane monomers. This breakthrough addresses two long-standing pain points in the industry: “difficulty balancing performance and cost” and “lack of a systematic gradient.” Different fluorine content fluorosilicone oils exhibit gradient variations in surface energy, solvent resistance, oil resistance, flexibility, and cost—low-fluorine products significantly enhance resistance at costs close to conventional silicone oils, while high-fluorine products provide extreme surface performance suitable for harsh environments.
      The significance of this technology lies in its enabling of “customization on demand” for downstream applications. For example, low-fluorine content products can be selected for cost-sensitive electronic consumer goods requiring some oil resistance, while high-fluorine content products can be deployed in extreme environments such as aerospace fuel systems. This “menu-based” product design capability will significantly expand the application boundaries of fluorosilicone oil.

High-End Product Mass Production: Medical and Aerospace Grades Achieve Import Substitution
      Simultaneously, multiple domestic enterprises have achieved industrialization breakthroughs in high-end specialty fluorosilicone oil. In April 2026, a Shandong-based fluorine-silicon material company received authorization for its patent titled “Vinyl-Containing Fluorinated Polysiloxane and Preparation Method Thereof.” This technology, through a novel copolymerization process, optimizes the molecular stability of fluorosilicone oil, significantly improving electrolyte resistance, high/low temperature resistance, and corrosion resistance while effectively reducing production costs, solving the long-standing industry pain points of “difficult mass production and high cost” for high-end functional fluorosilicone oil.
      The progress in medical-grade products is particularly notable. Over the past two years, overseas high-end medical fluorosilicone oil has experienced supply shortages, price increases, and extended delivery times due to supply chain issues, placing significant pressure on the supply chains of domestic medical device manufacturers. In response, multiple domestic enterprises have quickly filled the gap. Their medical-grade fluorosilicone oil has passed ISO10993 biocompatibility certification and offers advantages including high-temperature resistance, no leaching, high lubricity, and excellent biocompatibility, making it suitable for applications such as ultra-smooth coatings for minimally invasive medical catheters, mold release for medical devices, and surface modification of implantable medical devices. According to industry sources, domestic medical-grade fluorosilicone oil has achieved batch commercial production, with performance comparable to imported products, significantly reducing procurement costs for downstream enterprises.

Technology Roadmap Evolution: From General Purpose to Specialty
      Looking back at the technological development of fluorosilicone oil, a clear evolutionary path from “general-purpose” to “specialty high-end” emerges. In the past, domestic fluorosilicone oil production capacity was concentrated in general-purpose products with low technological barriers and limited added value, while high-end medical, aerospace, and semiconductor grades were long dependent on imports. Today, the industry‘s development focus has completely shifted, with enterprises no longer simply pursuing large-scale mass production but instead focusing on customized R&D for specific market segments.
      Leveraging new processes such as copolymerization modification and molecular structure optimization, domestic enterprises are developing specialty fluorosilicone oils tailored for medical biocompatibility, power battery electrolyte resistance, aerospace extreme temperature resistance, and semiconductor high-purity applications. These specialized products can precisely match downstream harsh operating conditions, solving pain points such as corrosion, aging, leaching, and insufficient lubrication, while significantly improving product premiums and market barriers.

Green and Smart: Dual Upgrades in Production Processes
       As domestic environmental policies continue to tighten, low VOCs, residue-free, and environmentally degradable properties have become core entry standards for fluorosilicone oil products. The industry is gradually phasing out traditional high-pollution, high-energy-consumption processes and popularizing green copolymerization and mild catalysis processes that reduce production waste and pollutant emissions. Meanwhile, the gradual implementation of intelligent production equipment has effectively stabilized product batch consistency and reduced mass production costs for high-end products, solving the long-standing industry problem of “difficult high-end product mass production with low yield rates.”
       Industry insiders point out that as technological barriers and downstream access standards continue to rise, small and medium-sized manufacturers lacking R&D capabilities and product diversity will gradually be eliminated from the market. Industry resources are continuously concentrating toward technology-oriented, large-scale enterprises, increasing market concentration and driving the fluorosilicone industry‘s transformation from extensive capacity expansion to a high-quality, high-value-added, refined development model.